Philip Choi, Charlotte Bradbury, Tomas Jose Gonzalez-Lopez, Muhlis Cem Ar, Karolin Trautmann-Grill, Mathias Rummel, Alessandra Borchiellini, Nicola Cooper, Fernando Chuliber, Rushad Patell, Blanca Sanchez, Patrick Urban, Alex Allepuz, Fabienne Le Gac, Renxin Lin, David Kuter. "Secondary analysis results from VAYHIT3, a phase 2 study of ianalumab in patients with primary immune thrombocytopenia previously treated with at least two lines of therapy." Blood, 2025. doi:10.1182/blood-2025-844